The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lupus


Psychiatry related information on Lupus


High impact information on Lupus


Chemical compound and disease context of Lupus


Biological context of Lupus


Anatomical context of Lupus


Gene context of Lupus


Analytical, diagnostic and therapeutic context of Lupus


  1. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Karassa, F.B., Isenberg, D.A. N. Engl. J. Med. (2001) [Pubmed]
  2. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. Gerhardt, A., Scharf, R.E., Beckmann, M.W., Struve, S., Bender, H.G., Pillny, M., Sandmann, W., Zotz, R.B. N. Engl. J. Med. (2000) [Pubmed]
  3. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Vang, T., Congia, M., Macis, M.D., Musumeci, L., Orrú, V., Zavattari, P., Nika, K., Tautz, L., Taskén, K., Cucca, F., Mustelin, T., Bottini, N. Nat. Genet. (2005) [Pubmed]
  4. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Barber, D.F., Bartolomé, A., Hernandez, C., Flores, J.M., Redondo, C., Fernandez-Arias, C., Camps, M., Rückle, T., Schwarz, M.K., Rodríguez, S., Martinez-A, C., Balomenos, D., Rommel, C., Carrera, A.C. Nat. Med. (2005) [Pubmed]
  5. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. McClain, M.T., Heinlen, L.D., Dennis, G.J., Roebuck, J., Harley, J.B., James, J.A. Nat. Med. (2005) [Pubmed]
  6. Development of antibodies to ribonucleoprotein following short-term therapy with procainamide. Winfield, J.B., Koffler, D., Kunkel, H.G. Arthritis Rheum. (1975) [Pubmed]
  7. Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia. Fricchione, G.L., Kaufman, L.D., Gruber, B.L., Fink, M. Am. J. Med. (1990) [Pubmed]
  8. Distribution of an anti-DNA idiotype among autoantibodies in patients with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA). Harkiss, G.D., Hendrie, F., Nuki, G. J. Clin. Immunol. (1986) [Pubmed]
  9. Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. Bae, S.C., Hashimoto, H., Karlson, E.W., Liang, M.H., Daltroy, L.H. J. Rheumatol. (2001) [Pubmed]
  10. Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjögren's syndrome. Utset, T.O., Golden, M., Siberry, G., Kiri, N., Crum, R.M., Petri, M. J. Rheumatol. (1994) [Pubmed]
  11. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. Chan, T.M., Li, F.K., Tang, C.S., Wong, R.W., Fang, G.X., Ji, Y.L., Lau, C.S., Wong, A.K., Tong, M.K., Chan, K.W., Lai, K.N. N. Engl. J. Med. (2000) [Pubmed]
  12. Diltiazem and subacute cutaneous lupus erythematosus-like lesions. Crowson, A.N., Magro, C.M. N. Engl. J. Med. (1995) [Pubmed]
  13. Improvement of renal function with selective thromboxane antagonism in lupus nephritis. Pierucci, A., Simonetti, B.M., Pecci, G., Mavrikakis, G., Feriozzi, S., Cinotti, G.A., Patrignani, P., Ciabattoni, G., Patrono, C. N. Engl. J. Med. (1989) [Pubmed]
  14. Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. Totoritis, M.C., Tan, E.M., McNally, E.M., Rubin, R.L. N. Engl. J. Med. (1988) [Pubmed]
  15. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. McCune, W.J., Golbus, J., Zeldes, W., Bohlke, P., Dunne, R., Fox, D.A. N. Engl. J. Med. (1988) [Pubmed]
  16. Hydrazine and lupus. Durant, P.J., Harris, R.A. N. Engl. J. Med. (1980) [Pubmed]
  17. Suppression of murine lupus erythematosus by dactinomycin. Gabrielsen, A.E., Lubert, A.S., Olsen, C.T. Nature (1976) [Pubmed]
  18. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. Woosley, R.L., Drayer, D.E., Reidenberg, M.M., Nies, A.S., Carr, K., Oates, J.A. N. Engl. J. Med. (1978) [Pubmed]
  19. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Jacob, C.O., McDevitt, H.O. Nature (1988) [Pubmed]
  20. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Morel, L., Tian, X.H., Croker, B.P., Wakeland, E.K. Immunity (1999) [Pubmed]
  21. The lupus anticoagulant in 14 male patients. Waddell, C.C., Brown, J.A. JAMA (1982) [Pubmed]
  22. Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice. Theofilopoulos, A.N., Balderas, R.S., Shawler, D.L., Lee, S., Dixon, F.J. J. Exp. Med. (1981) [Pubmed]
  23. Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. Cariou, R., Tobelem, G., Soria, C., Caen, J. N. Engl. J. Med. (1986) [Pubmed]
  24. Human lupus T cells resist inactivation and escape death by upregulating COX-2. Xu, L., Zhang, L., Yi, Y., Kang, H.K., Datta, S.K. Nat. Med. (2004) [Pubmed]
  25. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Gross, J.A., Johnston, J., Mudri, S., Enselman, R., Dillon, S.R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., Moore, M., Littau, A., Grossman, A., Haugen, H., Foley, K., Blumberg, H., Harrison, K., Kindsvogel, W., Clegg, C.H. Nature (2000) [Pubmed]
  26. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., Nagata, S. Nature (1992) [Pubmed]
  27. Human lupus inclusions and interferon. Rich, S.A. Science (1981) [Pubmed]
  28. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Boackle, S.A., Holers, V.M., Chen, X., Szakonyi, G., Karp, D.R., Wakeland, E.K., Morel, L. Immunity (2001) [Pubmed]
  29. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. Barrat, F.J., Meeker, T., Gregorio, J., Chan, J.H., Uematsu, S., Akira, S., Chang, B., Duramad, O., Coffman, R.L. J. Exp. Med. (2005) [Pubmed]
  30. Roles of interferon-gamma and interleukin-4 in murine lupus. Peng, S.L., Moslehi, J., Craft, J. J. Clin. Invest. (1997) [Pubmed]
  31. IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters. Gleicher, N., Friberg, J. JAMA (1985) [Pubmed]
  32. Insights into native epitopes of proliferating cell nuclear antigen using recombinant DNA protein products. Huff, J.P., Roos, G., Peebles, C.L., Houghten, R., Sullivan, K.F., Tan, E.M. J. Exp. Med. (1990) [Pubmed]
  33. Vaccination with minigenes encoding V(H)-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus. Fan, G.C., Singh, R.R. J. Exp. Med. (2002) [Pubmed]
WikiGenes - Universities